Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 386, Issue 25, Pages 2433-2435Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2203165
Keywords
-
Categories
Funding
- CDC
- Department of Health and Human Services
Ask authors/readers for more resources
The study assessed the protection against the omicron variant in individuals vaccinated with the adenovirus-based vaccine and received a booster dose of an mRNA vaccine. It was found that a single booster dose of an mRNA vaccine provided protection close to that of a three-dose mRNA vaccine regimen in recipients of the initial dose of Ad26.COV2.S.
Covid-19 Vaccine Boosters against Omicron Among persons vaccinated with the adenovirus-based vaccine who received a booster dose of an mRNA vaccine, protection against the omicron variant was assessed. A single booster dose of an mRNA vaccine in recipients of a single priming dose of Ad26.COV2.S provided protection close to that of a three-dose mRNA vaccine regimen.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
